Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioCryst (BCRX – Research Report), Arcturus Therapeutics (ARCT – Research Report) and Irhythm Technologies (IRTC – Research Report). BioCryst (BCRX) In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on BioCryst, with a price target of $30.00. The company's shares closed last Tuesday at $11.86. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biocryst-bcrx-arcturus-therapeutics-arct-and-irhythm-technologies-irtc?utm_source=advfn.com&utm_medium=referral
iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more iRhythm Technologies Charts.
iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more iRhythm Technologies Charts.